935106861
info@markelab.com
Precio
387.5€ (100 µg)
Magrolimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD47, Magrolimab is an anti-CD47 monoclonal antibody designed to promote the phagocytosis of cancer cells by macrophages. Magrolimab is an anti-CD47 monoclonal antibody. Its purpose is to interfere with the recognition of CD47 by SIRPα receptors on macrophages, thereby blocking the self-protection signal used by cancer cells to avoid phagocytosis by macrophages.
Biosimilars
Human
Monoclonal
Human
CD47
Human
IgG4 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 2169232-81-7
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más